These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2465188)

  • 1. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
    Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
    Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
    Lukács G; Balázs G; Zs-Nagy I; Juhász F
    Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
    Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
    Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
    Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
    Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Poorly differentiated carcinoma of the thyroid--immunohistochemical evaluation of p53 and p27 protein expression].
    Wierzchowski W; Szybiński P; Nowak W; Nowak K; Szybiński Z; Buziak-Bereza M; Stachura J
    Wiad Lek; 2001; 54 Suppl 1():79-87. PubMed ID: 12182066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nuclear DNA in neoplastic pathology of the thyroid gland].
    Sussi PL; Azzolina LS; Valerio A; Marchioretto F; Brazzarola P; Angeli G; Davì MV; Stival P; Finchi A; Francia G
    Chir Ital; 1994; 46(5):74-6. PubMed ID: 7788816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The measurement of DNA content and ploidy analysis in thyroid neoplasms.
    McLeod MK
    Otolaryngol Clin North Am; 1990 Apr; 23(2):271-90. PubMed ID: 2186336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
    Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ
    Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma.
    Bäckdahl M; Cohn K; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T; Willems JS; Zetterberg A
    Cancer Res; 1985 Jun; 45(6):2890-4. PubMed ID: 3986815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anaplastic transformation of papillary carcinoma of the thyroid].
    Gál I; Hatházi L; Nemes Z; Solymosi T
    Orv Hetil; 1994 Mar; 135(11):581-4. PubMed ID: 8159411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anaplastic transformation of differentiated thyroid carcinoma. An ultrastructural study.
    Dumitriu L; Stefăneanu L; Taşcă C
    Endocrinologie; 1984; 22(2):91-6. PubMed ID: 6740202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
    Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
    Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.